News Ticker

Immunoassay

Biosurfit 500 spinit® Instruments

April 17, 2017

Biosurfit SA (“biosurfit”), the in vitro point-of-care (PoC) diagnostics company, is pleased to announce that it has reached a significant commercial milestone, and also provides an update on recent progress. [more...]

Rainbow Seed Fund Invests in AgPlus Diagnostics

October 2, 2016

Rainbow Seed Fund, an early-stage venture capital fund focused on promising technologies developed at the UK’s largest publicly funded research facilities and campuses, today announces its investment into AgPlus Diagnostics, [more...]

Biosensia

September 16, 2014

Biosensia is an in vitro diagnostics company that has developed a novel point of care platform, RapiPlex. Biosensia’s proprietary RapiPlex platform integrates three technologies: A multi-channel fluidic chip Robust, well-established [more...]